Efficacy News and Research

RSS
VG Life Sciences provides update to HCQ-sorafenib combination Phase I Study for advanced stage solid tumors

VG Life Sciences provides update to HCQ-sorafenib combination Phase I Study for advanced stage solid tumors

Study: Antisense drugs show activity in wide range of tissues and organs

Study: Antisense drugs show activity in wide range of tissues and organs

NIH StrokeNet to revolutionize research on stroke

NIH StrokeNet to revolutionize research on stroke

Senhwa Biosciences raises additional $17 million USD in Series B financing

Senhwa Biosciences raises additional $17 million USD in Series B financing

Drug labeling often lacks infant-specific information, shows study

Drug labeling often lacks infant-specific information, shows study

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Medivir initiates phase IIa trial to evaluate efficacy of simeprevir combination therapy in HCV-infected patients

Medivir initiates phase IIa trial to evaluate efficacy of simeprevir combination therapy in HCV-infected patients

GSK's FluLaval Quadrivalent vaccine effective in reducing flu cases in children

GSK's FluLaval Quadrivalent vaccine effective in reducing flu cases in children

Tohoku University, Thomson Reuters team up to restore Tohoku’s medical system

Tohoku University, Thomson Reuters team up to restore Tohoku’s medical system

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

AP, Kaiser Permanente initiate clinical trial to evaluate the efficacy of Promescent lidocaine spray

AP, Kaiser Permanente initiate clinical trial to evaluate the efficacy of Promescent lidocaine spray

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

Early tumor shrinkage predicts targeted therapy efficacy in RCC

Early tumor shrinkage predicts targeted therapy efficacy in RCC

First patient enrolled in Otonomy's pivotal Phase 2b study of OTO-104 for Meniere's disease

First patient enrolled in Otonomy's pivotal Phase 2b study of OTO-104 for Meniere's disease

Daiichi Sankyo presents subgroup analysis of Hokusai-VTE study at ASH annual meeting

Daiichi Sankyo presents subgroup analysis of Hokusai-VTE study at ASH annual meeting

New research reveals novel way to develop anti-diarrhoeal drugs

New research reveals novel way to develop anti-diarrhoeal drugs

Study shows children with ALL can safely receive intravenous infusions of chemotherapy

Study shows children with ALL can safely receive intravenous infusions of chemotherapy

Experimental compound reduces joint inflammation in animal models of rheumatoid arthritis

Experimental compound reduces joint inflammation in animal models of rheumatoid arthritis

Budget cuts, years-long flat funding can delay research into effective treatments for cancer

Budget cuts, years-long flat funding can delay research into effective treatments for cancer

Pronai Therapeutics reports positive results from PNT2258 Phase II study on lymphoma

Pronai Therapeutics reports positive results from PNT2258 Phase II study on lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.